Global Global Sunitinib Malate Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI101005
Sunitinib Malate Market:
Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rising occurrence of pancreatic cancer, the convenience of a less drug therapeutic selections for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the early phases of pancreatic cancer are some key drivers for Global Sunitinib Malate Market.
Scope of Global Sunitinib Malate Market:
Sunitinib Malate is the small molecule, orally bioavailable malate salt of an indolinone-based multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the Food and Drug Administration (FDA) for the treatment of Carcinoma. Sunitinib Malate is having molecular formula C22H27FN4O2 so molecular weight is 398.482 g/mol. The possible antineoplastic activity of Sunitinib has managed to it being observed as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treatment of Pancreatic Neuroendocrine Tumors, Kidney Cancer and Gastrointestinal Stromal Tumor (GIST).Mechanism of action of Sunitinib Malate is it prevents cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib Malate also inhibits CD117 (c-KIT), the receptor tyrosine kinase that drives the many gastrointestinal stromal cell tumors. The side effects of Sunitinib Malate are Diarrhea, Heartburn, Hypertension, fatigue, Nausea and Vomiting, skin discoloration, cough, upset stomach, hair loss, fever, abdominal pain, shortness of breath, watery eyes, numbness or tingling of the arms or legs and swelling around the eyes. Global Sunitinib Malate Market has been segmented on the basis of Application and Geography. On the basis of Application Global Sunitinib Malate Market is classified into Pancreatic Neuroendocrine Tumors, Advanced Kidney Cancer, Gastrointestinal stromal tumor (GIST) and others. The regions covered in Global Sunitinib Malate Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Sunitinib Malate Market Key Players:
Pfizer
Topcare pharmaceutical Co. Ltd
Nanjing First Pharmaceutical Co. Ltd.
J&K Scientific
Target Molecule Corp.
Medichem
Biotechnica Pharma Global
Beijing Lunarsun Pharmaceutical Co. LTD
Brawn Laboratories Ltd INDIA
Hetero Drugs Ltd INDIA
Hikma Pharmaceutical plc
Jeil Pharmaceutical Co. Ltd
Natco Pharma LTD
Reliance Life Sciences Pvt. Ltd
Shilpa Medicare Ltd INDIA
Sichuan Xieli Pharmaceutical Co LTD
Synthland Ltd and Teva Pharmaceutical Industries Ltd.
Market Dynamics:
Rising incidence of pancreatic neuroendocrine tumors, pancreatic cancer is a main driver for the Global Sunitinib Malate Market. Likewise, accessibility of an inadequate number of drug therapeutics for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the initial phases of pancreatic cancer is increasing the demand of Sunitinib Malate in the treatment of pancreatic cancer. Conversely high cost of Sutent is one of the key restraints of the Global Sunitinib Malate Market growth. For 28 capsules of Sutent 37.5mg average cash price is $17,968.99. Some side effects of Sutent such as Hepatotoxicity and Adverse cardiovascular events like heart failure, myocardial infarction and coronary artery bypass grafting have also been reported during clinical trials, which could discourage adoption of the drug. Increase in awareness about the disease and technological expansions are likely to raise the Global Sunitinib Malate Market. Also Rising Prevalence of Cancer, Increase in Pharmaceutical R&D Spending, Rising Healthcare Expenditure and Rising Asian Population will boost the Global Sunitinib Malate Market. Systematic Drugs under Pipeline, Rising Scope for Cancer Therapy and increasing awareness towards Carcinoma are some opportunities in the forecast period for the Global Sunitinib Malate Market.
Regional Analysis:
North America holds the largest share of Global Sunitinib Malate Market amongst others. It is mainly driven by quickly increasing incidence of pancreatic cancer. Moreover the incomes of customers and health insurance cover for life-threatening diseases in U.S. are very high which raises the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the progress of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase therefore hastening the clinical development. Asia-Pacific is likely to grow vastly in the future due to some factors such as high occurrence of cancer, rising awareness regarding cure and treatment of cancer and increasing partnership between public and private areas to offer innovative cancer therapy in the region. The incidence of various types of cancer is much more in developing countries which concentrate these regions as favorable locations to conduct clinical trials. Furthermore the cost of clinical research is less in these regions due to the accessibility of a vast population base and favorable government policies contributing to the cancer drugs market growth in the developing countries.
Sunitinib Malate Market Segmentation:
By Application
Pancreatic Neuroendocrine Tumors
Advanced Kidney Cancer
Gastrointestinal stromal tumor (GIST)
Other
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America - Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Sunitinib Malate Market
Chapter 5. Global Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
5.1. Global Sunitinib Malate Market Share, By Application, 2015 - 2028 (USD Million)
5.1.1. Pancreatic Neuroendocrine Tumors
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Advanced Kidney Cancer
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.3. Gastrointestinal stromal tumor (GIST)
5.1.3.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.4. Other
5.1.4.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Sunitinib Malate Market Overview, By Geography, 2015 - 2028(USD Million)
6.1. Global Sunitinib Malate Market Share, By Geography, 2015 - 2028(USD Million)
6.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 7. North America Sunitinib Malate Market Overview, By Countries, 2015 - 2028(USD Million)
7.1. North America Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
7.1.1. Market Size and projections, 2015 - 2028 (USD Million)
7.1.2. North America Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
7.1.3. North America Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
7.1.3.1. U.S. Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
7.1.3.1.1. Market Size and projections, 2015 - 2028 (USD Million)
7.1.3.1.2. U.S. Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
7.1.3.2. Canada Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
7.1.3.2.1. Market Size and projections, 2015 - 2028 (USD Million)
7.1.3.2.2. Canada Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
7.1.3.3. Mexico Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
7.1.3.3.1. Market Size and projections, 2015 - 2028 (USD Million)
7.1.3.3.2. Mexico Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
Chapter 8. Europe Sunitinib Malate Market Overview, By Countries, 2015 - 2028(USD Million)
8.1. Europe Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
8.1.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.2. Europe Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
8.1.3. Europe Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
8.1.3.1. Germany
8.1.3.1.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.3.1.2. Germany Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
8.1.3.2. France
8.1.3.2.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.3.2.2. France Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
8.1.3.3. UK
8.1.3.3.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.3.3.2. UK Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
8.1.3.4. Italy
8.1.3.4.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.3.4.2. Italy Sunitinib Malate Market Overview, By Application 2015 - 2028(USD Million)
8.1.3.5. Spain
8.1.3.5.1. Market Size and projections, 2015 - 2028 (USD Million)
8.1.3.5.2. Spain Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
8.1.3.6. Rest of Europe
8.1.3.6.1. Market Size and projections, 2015 – 2028
8.1.3.6.2. Rest of Europe Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
Chapter 9. Asia Pacific Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1. Asia Pacific Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. Asia Pacific Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
9.1.3. Asia Pacific Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.3.1. India
9.1.3.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.3.1.2. India Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
9.1.3.1.3. Other Segments
9.1.3.2. China
9.1.3.2.1. Market Size and projections, 2015 - 2028(USD Million)
9.1.3.2.2. China Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
9.1.3.3. Japan
9.1.3.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.3.3.2. Japan Sunitinib Malate Market Overview, By Application, 2015 - 2028(USD Million)
9.1.3.4. South Korea
9.1.3.4.1. Market Size and projections, 2015 - 2028(USD Million)
9.1.3.4.2. South Korea Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
9.1.3.5. Rest of Asia Pacific
9.1.3.5.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.3.5.2. Rest of Asia Pacific Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
Chapter 10. Middle East & Africa Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1. Middle East & Africa Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Middle East & Africa Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
10.1.3. Middle East & Africa Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.3.1. GCC
10.1.3.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.3.1.2. GCC Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
10.1.3.2. South Africa
10.1.3.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.3.2.2. South Africa Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
10.1.3.3. Rest of Middle East & Africa
10.1.3.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.3.3.2. Rest of Middle East & Africa Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
Chapter 11. South America Sunitinib Malate Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. South America Sunitinib Malate Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. South America Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
11.1.3. South America Sunitinib Malate Market Overview, By Countries, 2015- 2026 (USD Million)
11.1.4. Brazil
11.1.4.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.4.2. Brazil Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
11.1.5. Argentina
11.1.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.2. Argentina Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
11.1.6. Rest of South America
11.1.6.1. Market Size and projections, 2015 – 2028
11.1.6.2. Rest of South America Sunitinib Malate Market Overview, By Application, 2015 - 2028 (USD Million)
Chapter 12. Competitive Landscape
12.1. Competitive environment, 2020
12.2. Strategic framework
12.2.1. Partnership/agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Offering development
Chapter 13. Key Vendor Analysis
13.1. Pfizer
13.1.1. Company overview
13.1.2. Financial performance
13.1.3. Mice Benchmarking
13.1.4. Recent initiatives
13.1.5. SWOT analysis
13.2. Topcare pharmaceutical Co. Ltd
13.2.1. Company overview
13.2.2. Financial performance
13.2.3. Mice Benchmarking
13.2.4. Recent initiatives
13.2.5. SWOT analysis
13.3. Nanjing First Pharmaceutical Co. Ltd.
13.3.1. Company overview
13.3.2. Financial performance
13.3.3. Mice Benchmarking
13.3.4. Recent initiatives
13.4. J&K Scientific
13.5. Target Molecule Corp.
13.6. Medichem
13.7. Biotechnica Pharma Global
13.8. Beijing Lunarsun Pharmaceutical Co. Ltd
13.9. Brawn Laboratories Ltd
13.10. Hetero Drugs Ltd
13.11. Other
Chapter 14. Sunitinib Malate Market Cost Analysis
14.1. Sunitinib Malate Market Key Offering Analysis
14.1.1. Key Offering
14.1.2. Price Trend of Key Raw Material
14.1.3. Key Suppliers
14.1.4. Labor Cost
Chapter 15. Industrial Chain, Sourcing Strategy and Downstream Buyers
15.1. Sunitinib Malate Market Industrial Chain Analysis
15.2. Upstream Offering Sourcing
15.3. Raw Material Sources of Sunitinib Malate Market Major Manufacturers in 2021
15.4. Downstream Buyers
Chapter 16. Marketing Strategy Analysis, Distributors/Pancreatic Neuroendocrine Tumors
16.1. Marketing Channel
16.1.1. Direct Marketing
16.1.2. Indirect Marketing
16.1.3. Marketing Channel Development Trend
16.2. Market Positioning
16.2.1. Pricing Strategy
16.2.2. Brand Strategy
16.2.3. Target Client
16.3. Distributors/Pancreatic Neuroendocrine Tumors List
Chapter 17. Market Effect Factors Analysis
17.1. Technology Progress/Risk
17.1.1. Substitutes Threat
17.1.2. Technology Progress in Related Size
17.2. Consumer Needs/Customer Preference Change
17.3. Economic/Political Environmental Change
Chapter 18. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Sunitinib Malate Market, 2015-2028 (USD Million)
4. North America Sunitinib Malate Market, by Product, 2015-2028 (USD Million)
5. Europe Sunitinib Malate Market, by Product, 2015-2028 (USD Million)
6. Asia Pacific Sunitinib Malate Market, by Product, 2015-2028 (Revenue, USD Million)
7. Middle East & Africa Sunitinib Malate Market, by Product, 2015-2028 (USD Million)
8. South America Sunitinib Malate Market, by Product, 2015-2028 (USD Million)
9. Global Sunitinib Malate Market, Company Market Share, 2020 - 2028 (%)
10. Pfizer : Product Benchmarking
11. Pfizer : Financial Performance
12. Topcare pharmaceutical Co. Ltd : Product Benchmarking
13. Topcare pharmaceutical Co. Ltd : Financial Performance
14. Nanjing First Pharmaceutical Co. Ltd. : Product Benchmarking
15. Nanjing First Pharmaceutical Co. Ltd. : Financial Performance
16. J&K Scientific :Product Benchmarking
17. J&K Scientific :Financial Performance
18. Target Molecule Corp. : Product Benchmarking
19. Target Molecule Corp. : Financial Performance
20. Medichem: Product Benchmarking
21. Medichem: Financial Performance
22. Biotechnica Pharma Global: Product Benchmarking
23. Biotechnica Pharma Global: Financial Performance
24. Beijing Lunarsun Pharmaceutical Co. Ltd: Product Benchmarking
25. Beijing Lunarsun Pharmaceutical Co. Ltd: Financial Performance
26. Brawn Laboratories Ltd: Product Benchmarking
27. Brawn Laboratories Ltd: Financial Performance
28. Hetero Drugs Ltd: Product Benchmarking
29. Hetero Drugs Ltd: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Sunitinib Malate Market share, by Product, 2020 & 2028 (%)
10. Global Sunitinib Malate Market share, by Pancreatic Neuroendocrine Tumors, by Product, 2015 - 2028 (USD Million)
11. Global Sunitinib Malate Market share, by Advanced Kidney Cancer, by Product, 2015 - 2028 (USD Million)
12. Global Sunitinib Malate Market share, by Gastrointestinal stromal tumor (GIST), by Product, 2015 - 2028 (USD Million)
13. Global Sunitinib Malate Market share, by Other, by Product, 2015 - 2028 (USD Million)
14. Global Sunitinib Malate Market share, by region, 2020 & 2028 (%)
15. Global Sunitinib Malate Market share, by region, 2015 - 2028(USD Million)
16. North America Sunitinib Malate Market, 2015 - 2028(USD Million)
17. North America Sunitinib Malate Market share, by Countries, 2020 & 2028 (%)
18. U.S. Sunitinib Malate Market, 2015 - 2028(USD Million)
19. Canada Sunitinib Malate Market, 2015 - 2028(USD Million)
20. Europe Sunitinib Malate Market, 2015 - 2028(USD Million)
21. Europe Sunitinib Malate Market share, by Countries, 2020 & 2028 (%)
22. Spain Sunitinib Malate Market, 2015 - 2028(USD Million)
23. UK Sunitinib Malate Market, 2015 - 2028(USD Million)
24. Italy Sunitinib Malate Market, 2015 - 2028(USD Million)
25. Germany Sunitinib Malate Market, 2015 - 2028(USD Million)
26. France Sunitinib Malate Market, 2015 - 2028(USD Million)
27. Rest of Europe Sunitinib Malate Market, 2015 - 2028(USD Million)
28. Asia-Pacific Sunitinib Malate Market, 2015 - 2028(USD Million)
29. Asia-Pacific Sunitinib Malate Market share, by Countries, 2020 & 2028 (%)
30. China Sunitinib Malate Market, 2015 - 2028(USD Million)
31. India Sunitinib Malate Market, 2015 - 2028(USD Million)
32. Australia Sunitinib Malate Market, 2015 - 2028(USD Million)
33. Japan Sunitinib Malate Market, 2015 - 2028(USD Million)
34. Rest of Asia-Pacific Sunitinib Malate Market, 2015 - 2028(USD Million)
35. Middle East & Africa Sunitinib Malate Market, 2015 - 2028(USD Million)
36. Middle East & Africa Sunitinib Malate Market share, by Countries, 2020 & 2028 (%)
37. GCC Sunitinib Malate Market, 2015 - 2028(USD Million)
38. South Africa Sunitinib Malate Market, 2015 - 2028(USD Million)
39. Rest of Middle East & Africa Sunitinib Malate Market, 2015 - 2028(USD Million)
40. South America Sunitinib Malate Market, 2015 - 2028(USD Million)
41. Brazil Sunitinib Malate Market, 2015 - 2028(USD Million)
42. Mexico Sunitinib Malate Market, 2015 - 2028(USD Million)
43. Argentina Sunitinib Malate Market, 2015 - 2028(USD Million)
44. Rest Of South America Sunitinib Malate Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Global Sunitinib Malate Market
